Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/58882
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomas, J.en
dc.contributor.authorMuller, P.en
dc.contributor.authorWilkinson, C.en
dc.date.issued2007en
dc.identifier.citationThe Cochrane Database of Systematic Reviews, 2007; 2(2):CD005541en
dc.identifier.issn1469-493Xen
dc.identifier.issn1469-493Xen
dc.identifier.urihttp://hdl.handle.net/2440/58882-
dc.descriptionThis version first published online: April 18. 2007 Last assessed as up-to-date: June 24. 2009en
dc.description.abstractBackground Neonates from isoimmunized pregnancies have increased morbidity from neonatal jaundice. The increased bilirubin from haemolysis often needs phototherapy, exchange transfusion or both after birth. Various trials in pregnant women who were not isoimmunized but had other risk factors for neonatal jaundice have shown a reduction in need for phototherapy and exchange transfusion by the use of antenatal phenobarbital. A recent retrospective case-controlled study showed reduction in the need for exchange transfusion for the neonates from isoimmunized pregnancies. Objectives To assess the effects of antenatal phenobarbital in red cell isoimmunized pregnancies in reducing the incidence of phototherapy and exchange transfusion for the neonate. Search strategy We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (June 2009). Selection criteria Randomised and quasi-randomised controlled trials of pregnant women established to have red cell isoimmunization in the current pregnancy during their antenatal testing and given phenobarbital alone or in combination with other drugs before birth. Data collection and analysis All three review authors independently assessed study eligibility and quality. Main results No trials met the inclusion criteria for this review. Authors' conclusions The use of antenatal phenobarbital to reduce neonatal jaundice in red cell isoimmunized pregnant women has not been evaluated in randomised controlled trials.en
dc.description.statementofresponsibilityJoseph T Thomas, Peter Muller, Christopher S Wilkinsonen
dc.language.isoenen
dc.publisherUpdate Software Ltden
dc.rightsCopyright © 2009 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd..en
dc.subjectHumans; Rh Isoimmunization; Jaundice, Neonatal; Phenobarbital; Excitatory Amino Acid Antagonists; Prenatal Care; Pregnancy; Infant, Newborn; Femaleen
dc.titleAntenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunizationen
dc.typeJournal articleen
dc.identifier.doi10.1002/14651858.CD005541.pub2en
pubs.publication-statusPublisheden
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.